TIA JANICKI: Open Payments
NPI 1972636843 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 55 payments from 16 companies in 2025. Trend: 2023 $1,638 · 2024 $2,286 · 2025 $1,438
Food & beverage: $1,188Education: $250
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $219 |
| Novartis Pharmaceuticals Corporation | 11 | $169 |
| GENZYME CORPORATION | 6 | $164 |
| Incyte Corporation | 4 | $164 |
| Janssen Biotech, Inc. | 2 | $150 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Galderma Laboratories, L.P. | 5 | $96 |
| ABBVIE INC. | 3 | $81 |
| Organogenesis Inc. | 3 | $67 |
Products named: DUPIXENT, Bimzelx, OPZELURA, TREMFYA, NEMLUVIO, RINVOQ, NOVACHOR, COSENTYX.
Industry payments across AL — which companies pay providers there.
